Light therapy for memory and brain health
Part of Brain & nervous system clinical trials.
This study tests whether a type of light therapy called photobiomodulation can improve brain connections and thinking abilities in people with mild memory problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 55 years of age or older.
- You must have been diagnosed with mild cognitive impairment that mainly affects your memory.
- You cannot have a neurological disorder like Parkinson's or stroke.
- You cannot have a severe psychiatric condition like major depression or schizophrenia.
- You must not have a pacemaker or any implanted device that is not safe for MRI scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if shining a special light through the scalp and nose can help people with mild memory or thinking problems. It aims to slow down memory decline and improve daily life.
This study tests whether light therapy can help improve thinking and memory in older adults with mild cognitive changes. Researchers will use light exposure to see if it supports brain health in people with signs of blood vessel disease in the brain.
This study tests a light-based therapy (photobiomodulation) applied to the head to see if it can improve thinking and memory by boosting energy in brain cells. It may help healthy adults sharpen their cognitive abilities.
This study tests whether shining a special non-invasive light on the head (photobiomodulation) can improve memory and mood in older adults who feel their memory is slipping but do not have a diagnosed condition. If you notice memory changes and are concerned, this treatment might help.
This study tests whether shining a gentle infrared light on the head can help people with mild memory loss (MCI) improve their thinking and memory. It is designed for those who have mild cognitive impairment due to early Alzheimer's disease.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
Hear when a new AMCI - Amnestic Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.